| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:962-968.)
© 2004 American Heart Association, Inc.
Original Articles |
From the Cardiovascular Division (D.A.N., R.V., M.E.D., R.T.L.), Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, and the Division of Biological Engineering, Massachusetts Institute of Technology (D.A.N., R.D.K., R.T.L.), Cambridge, Mass.
Correspondence to Richard T. Lee, MD, Partners Research Facility, Room 279, 65 Landsdowne St, Cambridge, MA 02139. E-mail rlee{at}rics.bwh.harvard.edu
Received July 8, 2003; de novo received December 17, 2003; revision received March 16, 2004; accepted March 22, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results Microvascular ECs and neonatal CMs were seeded on peptide hydrogels in 1 of 3 experimental configurations: CMs alone, CMs mixed with ECs (coculture), or CMs seeded on preformed EC networks (prevascularized). Capillary-like networks formed by ECs promoted marked CM reorganization along the EC structures, in contrast to limited organization of CMs cultured alone. The presence of ECs markedly inhibited CM apoptosis and necrosis at all time points. In addition, CMs on preformed EC networks resulted in significantly less CM apoptosis and necrosis compared with simultaneous EC-CM seeding (P<0.01, ANOVA). Furthermore, ECs promoted synchronized contraction of CMs as well as connexin 43 expression.
Conclusions These results provide direct evidence for a novel role of endothelium in survival and organization of nearby CMs. Successful strategies for cardiac regeneration may therefore depend on establishing functional CMendothelium interactions.
Key Words: endothelium cardiomyopathy heart failure tissue
| Introduction |
|---|
|
|
|---|
Several approaches in cell transplantation and cardiac tissue engineering have been investigated as potential treatments to enhance cardiac function after myocardial injury.9,10 Implantation of skeletal muscle cells, bone marrow cells, embryonic stem cellderived CMs, and myoblasts can enhance cardiac function.11 Cell-seeded grafts have been used instead of isolated cells for in vitro cardiac tissue growth or in vivo transplantation.1218 These grafts can develop a high degree of myocyte spatial organization, differentiation, and spontaneous and coordinated contractions. On implantation in vivo, cardiac grafts can integrate into the host tissue and neovascularization can develop. However, the presence of scar tissue and the death of cells in the graft can limit the amount of new myocardium formed,15,16,19 most likely due to ischemia.19 Therefore, creating a favorable environment to promote survival of transplanted cells and differentiation of progenitor cells remains one of the most important steps in regeneration of heart tissue.
One of the key factors for myocardial regeneration is revascularization of damaged tissue. In the normal heart, there is a capillary next to almost every CM, and endothelial cells (ECs) outnumber cardiomyocytes by
3:1.20 Developmental biology experiments reveal that myocardial cell maturation and function depend on the presence of endocardial endothelium at an early stage.20 Experiments with inactivation or overexpression of vascular endothelial growth factor (VEGF) demonstrated that at later stages, either an excess or a deficit in blood vessel formation results in lethality due to cardiac dysfunction.2023 Both endocardium and myocardial capillaries have been shown to modulate cardiac performance, rhythmicity, and growth.24 In addition, a recent study showed the critical importance of CM-derived VEGF in paracrine regulation of cardiac morphogenesis.25 These findings and others highlight the significance of interactions between CMs and endothelium for normal cardiac function. However, little is known about the specific mechanisms for these interactions, as well as the role of a complex, 3-dimensional organization of myocytes, ECs, and fibroblasts in the maintenance of healthy cardiac muscle.
The critical relation of CMs and the microvasculature suggests that successful cardiac regeneration will require a strategy that promotes survival of both ECs and CMs. The present study explored the hypothesis that ECs (both as preexisting capillary-like structures and mixed with myocytes at the time of seeding) promote myocyte survival and enhance spatial reorganization in a 3-dimensional configuration. The results demonstrate that CM interactions with ECs markedly decrease myocyte death and show that endothelium may be important not only for the delivery of blood and oxygen but also for the formation and maintenance of myocardial structure.
| Methods |
|---|
|
|
|---|
Three-Dimensional Culture
Cells were cultured in 3-dimensional, 1% peptide hydrogel scaffolds (peptide sequence AcN-RARADADARARADADA-CNH2).30 To test whether ECs promote CM survival, 3 experimental groups were established: (1) CMs alone; (2) EC-CM coculture, wherein ECs and CMs were seeded at the same time; and (3) prevascularized, wherein EC networks were preformed by seeding ECs 1 day before CMs were added. To test whether the effect of ECs on myocyte survival is endothelium specific, we also performed experiments with myocyte-fibroblast cocultures. The cell seeding density was 0.7x106 cells/cm2 (CMs alone) or 1.4x106 cells/cm2 (both coculture groups and the prevascularized group in a 1:1 CM-nonmyocyte cell ratio). To exclude the possibility that the increasing cell density of added ECs caused the myocyte spatial reorganization, control experiments were performed with myocytes seeded separately at a density of 1.4x106 cells/cm2. In addition, control cultures with ECs only at seeding densities of 1.4x106 or 0.7x106 cells/cm2 were used to ensure that the presence of myocytes did not affect the EC ability to form capillary-like networks. To test whether the effect of ECs on myocyte survival required cell contact, CMs were cultured with EC-conditioned medium. All experiments were performed in triplicate. Cells were cultured for up to 7 days at 37°C and 5% CO2 in culture medium (10% fetal calf serum), with the medium being changed on days 2, 4, and 6.
Immunohistochemistry and Cell Death Assays
Cells were analyzed with the live/dead viability/cytotoxicity kit (Molecular Probes). For immunohistochemical analyses, the samples were fixed in 2% formaldehyde for 1 hour, rinsed with phosphate-buffered saline, permeabilized with 0.1% Triton X-100 in phosphate-buffered saline for 1 hour, and incubated with blocking buffer (20% fetal calf serum and 0.1% Triton X-100 in phosphate-buffered saline) for 2 hours at room temperature. Cultures were incubated with primary antibodies (mouse monoclonal anti
-actinin, clone EA-53 [Sigma]), mouse anti-connexin [Cx]43 monoclonal antibody [Sigma], or rabbit anti-human antivon Willebrand factor [Sigma]) for 30 minutes at room temperature, with subsequent washing in the blocking buffer overnight, followed by incubation with the secondary antibodies (Alexa Fluor 488 goat anti-mouse IgG1, Alexa Fluor 594 goat anti-mouse IgM [both from Molecular Probes] or goat anti-rabbit IgGfluorescein isothiocyanate [Sigma]) for 30 minutes. Finally, cultures were incubated with 4'6-diamidino-2-phenylindole (DAPI; Molecular Probes) to visualize cell nuclei. Samples incubated with secondary antibodies served as negative controls only.
Apoptosis was determined using a terminal dUTP nick end-labeling (TUNEL) kit (Roche) according to the manufacturers instructions. In brief, samples were fixed and stained by the immunofluorescent staining protocol described earlier, followed by exposure to a reaction mix containing terminal deoxynucleotidyl transferase and nucleotide mixture in equilibration buffer for 60 minutes at 37°C. For both TUNEL and necrosis assays, images of 3 different areas of each sample were taken with a fluorescence microscope, and the ratio of TUNEL-positive or necrotic CMs to the total number of myocytes was calculated for that sample, with myocytes identified as actinin-positive cells.
For high-resolution analysis of cell structures formed in EC-CM cocultures, cells were labeled with CellTracker dyes (green 5-chloromethylfluorescein diacetate [CMFDA] for ECs and orange 5-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine [CMRA] for myocytes) before being seeded on the peptide hydrogel. Cells were then cocultured for 3 days and fixed. Samples were embedded in paraffin, and 5-µm-thick slices were obtained and analyzed by fluorescence microscopy.
Evaluation of Contractile Areas
To compare the areas of spontaneous contractions, 80-frame videos were taken with a videomicroscope (25 ms/frame) of 3 randomly selected regions of each sample containing at least 100 cells. Contracting cells or cell clusters and structures contracting in synchrony were selected, and average areas of contracting regions were calculated for each image with Matlab (The Mathworks, Inc) and custom-written software.
Statistics
ANOVA with post hoc t tests and Bonferroni corrections was used. A probability value <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
To establish that both myocytes and ECs were forming networks together, we performed immunofluorescence studies with specific antibodies, as well as analysis of cross sections of CM-EC cocultures, whereby cells were labeled with CellTracker dyes before seeding. Immunofluorescent staining demonstrated that >95% of CMs were present within these networks, suggesting that CMs preferentially migrate to or survive better near ECs (Figure 2). The analysis of cross sections demonstrated the presence of what appeared to be EC-derived, tubelike structures (Figure 3), with myocytes spread on the outer part of the capillary wall. Along with the capillary-like structures, clusters of intermingled cells (both myocytes and ECs) not containing the lumen were also observed (not shown). However, when the lumen was present, ECs were always on the inner side and myocytes on the outer side of the structure.
|
|
In CM-fibroblast cocultures, cells rapidly (within 24 hours) formed large clusters consisting of cells of both types (not shown). At later time points, fibroblast proliferation resulted in their migration outside the clusters and spreading on the hydrogel without any pattern. However, in contrast to EC-CM cocultures, CMs remained in the clusters and demonstrated only limited spreading. Immunofluorescent staining revealed that there was no orientation of myocytes relative to the fibroblasts in the clusters. In cultures with EC-conditioned medium, myocyte morphology and spatial organization remained similar to those of myocyte controls.
ECs Improve Survival of CMs
To test the hypothesis that ECs promote CM survival, we assessed apoptosis and necrosis in the 3-dimensional cultures. Quantitative analyses of CMs positive for TUNEL and necrosis staining demonstrated significantly decreased myocyte apoptosis and necrosis when cultured with ECs, compared with CM-only cultures (Figure 4, P<0.01). This effect was observed at all 3 time points, although the decreased necrosis was most pronounced at day 1. In addition, CMs seeded on the preformed EC networks had a lower rate of apoptosis at day 1 relative to same-time seeding cultures (P<0.05, post hoc test), suggesting that early EC-CM interactions provided by the presence of well-attached and prearranged ECs may further promote CM survival. In contrast to the ECs, cardiac fibroblasts did not affect myocyte survival (P>0.05, Figure 4), with ratios for myocyte apoptosis and necrosis in the myocyte-fibroblast cocultures being similar to those for myocyte-only controls. However, addition of EC-conditioned medium resulted in a significant decrease in apoptosis and necrosis ratios of myocytes (P<0.01). Interestingly, the effect of conditioned medium on myocyte necrosis was similar in magnitude to the effect of ECs, whereas myocyte apoptosis ratios in the conditioned-medium group were only partially decreased compared with those in the presence of ECs. These results suggest that the prosurvival effect of ECs on CMs may not only be merely due to the local interactions between myocytes and ECs during myocyte attachment but may also involve direct signaling between myocytes and ECs.
|
Preformed Endothelial Networks Promote Coordinated, Spontaneous Contractions
In the prevascularized group with preformed vascular structures, synchronized, spontaneous contractions of large areas (Figure 5, top panels) were detected as early as days 2 to 3 after seeding, in contrast to the coculture group, wherein such contractions were observed on days 6 to 7. In CM-only cultures, beating of separate cells and small cell clusters was also detected at days 2 to 3, similar to that in the prevascularized group. However, the average area of synchronized beating at day 3 in the myocyte-only group (3.5±0.5x102 µm2) was nearly 3 orders of magnitude smaller than the synchronously contracting area in the prevascularized group (4.3±2.5x105 µm2, mean±SD, n=5). These data suggest that ECs promote synchronized CM contraction, particularly when vascular networks are already formed.
|
ECs Promote Cx43 Expression
Staining for Cx43 showed striking differences in the distribution pattern of this gap junction protein between EC-CM cocultures and CMs cultured alone. In myocyte-only cultures, Cx43 expression was barely detectable at day 1 (not shown); at days 3 and 7, Cx43 expression was sparse throughout the cell clusters (Figure 6). In the presence of ECs (in both coculture and prevascularized groups), Cx43 staining was evident at day 1, both between ECs and distributed among CMs. As early as day 3 in culture, patches of localized junction-like Cx43, in addition to diffuse staining, were observed for myocytes in the coculture group (Figure 6). In the prevascularized group at day 3, wherein spontaneous contractions were already observed, more junction-like patches of Cx43 were observed compared with the coculture group, indicating electrical connections between myocytes (Figure 6). In addition to junctions between myocytes, there was also evidence of Cx43 localized at the interface between ECs and myocytes (Figure 6) detected in both the coculture group (at day 7) and the preculture group (as early as day 3). When myocytes and myocyte-EC coculture groups were cultured for 3 days with or without addition of 100 ng/mL of neutralizing anti-mouse VEGF antibody (R&D Systems), we observed no differences in either apoptosis or Cx43 staining between VEGF antibodycontaining cultures and controls.
|
| Discussion |
|---|
|
|
|---|
Our data suggesting improved synchrony of myocytes in the presence of ECs raise the intriguing hypothesis that electrical organization in the heart may be guided by vascular networks. This hypothesis is further supported by a recent study showing that the endothelium in arterioles can support electrical coupling as the mode of signal transmission.32 Previously, functional Cx43 channels have been described for both myocyte-myocyte and endothelial-endothelial cell junctions.3336 In addition, a possible presence of myoendothelial Cx43 gap junctions between smooth muscle cells and endothelium in arterioles of the hamster cheek pouch has been suggested.32,34 Our results suggest that heterocellular endothelial-CM junctions may exist between CMs and ECs, which has not been reported for adult cardiac tissue.24 Interestingly, a recent study demonstrated that VEGF enhanced Cx43 expression in myocytes,37 suggesting that a VEGF-dependent mechanism for signaling between ECs and myocytes may also play a role in our system. We observed no differences in either apoptosis or Cx43 staining between VEGF antibodycontaining cultures and controls; further experiments will be necessary to determine whether other cytokines or growth factors mediate these effects. It is important to note that the observed difference in Cx43 staining and improved electrical connectivity in the presence of endothelial structures may be merely a consequence of better myocyte spreading and survival, rather than biological interactions between ECs and CMs.
Irrespective of which strategy is used to regenerate myocardium, establishing or maintaining a functional and stable capillary network will be crucial for myocardial performance. In addition to maintaining a minimum intercapillary distance to provide oxygen and nutrients, the endothelium may directly affect myocyte function. For example, cardiac ECs produce nitric oxide, endothelin, and prostacyclin; all of these molecules can affect cardiac growth and contractility. These results are highly consistent with experiments in developmental biology that demonstrate dependence of cardiac development on endothelial signals.20,36
In conclusion, the presence of EC networks profoundly improves CM survival and organization. These data have broad implications for cardiac tissue engineering and suggest that strategies that deliver myocytes or ECs alone may not be sufficient, unless endogenous mechanisms can recruit or maintain the complementary cells. Ultimately, the survival and function of transplanted myocytes may depend on nearby ECs.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. E. Semino Self-assembling Peptides: From Bio-inspired Materials to Bone Regeneration J. Dent. Res., July 1, 2008; 87(7): 606 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Smart and P. R. Riley The Stem Cell Movement Circ. Res., May 23, 2008; 102(10): 1155 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Schuleri, L. C. Amado, A. J. Boyle, M. Centola, A. P. Saliaris, M. R. Gutman, K. E. Hatzistergos, B. N. Oskouei, J. M. Zimmet, R. G. Young, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2002 - H2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Caspi, A. Lesman, Y. Basevitch, A. Gepstein, G. Arbel, I. H. M. Habib, L. Gepstein, and S. Levenberg Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells Circ. Res., February 2, 2007; 100(2): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Morritt, S. K. Bortolotto, R. J. Dilley, X. Han, A. R. Kompa, D. McCombe, C. E. Wright, S. Itescu, J. A. Angus, and W. A. Morrison Cardiac Tissue Engineering in an In Vivo Vascularized Chamber Circulation, January 23, 2007; 115(3): 353 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Guo, Y.-S. Zhao, H.-X. Chang, C.-Y. Wang, L.-L. E, X.-A. Zhang, C.-M. Duan, L.-Z. Dong, H. Jiang, J. Li, et al. Creation of Engineered Cardiac Tissue In Vitro From Mouse Embryonic Stem Cells Circulation, May 9, 2006; 113(18): 2229 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, M. Ohishi, T. Katsuya, N. Ito, M. Ikushima, M. Kaibe, Y. Tatara, A. Shiota, S. Sugano, S. Takeda, et al. Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II Hypertension, April 1, 2006; 47(4): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ma, H.-F. Zhang, L. Yu, Q.-J. Zhang, J. Li, J.-H. Huo, X. Li, W.-Y. Guo, H.-C. Wang, and F. Gao Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: Role of Akt-stimulated NO production Cardiovasc Res, January 1, 2006; 69(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eschenhagen and W. H. Zimmermann Engineering Myocardial Tissue Circ. Res., December 9, 2005; 97(12): 1220 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Davis, P. C.H. Hsieh, A. J. Grodzinsky, and R. T. Lee Custom Design of the Cardiac Microenvironment With Biomaterials Circ. Res., July 8, 2005; 97(1): 8 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Davis, J.P. M. Motion, D. A. Narmoneva, T. Takahashi, D. Hakuno, R. D. Kamm, S. Zhang, and R. T. Lee Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells Circulation, February 1, 2005; 111(4): 442 - 450. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |